CustoMED
PrivateLast Round
Seed
Oct 29, 2025
Total Funding Raised
$7.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CustoMED operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in October 2025.
CustoMED is a healthtech company that provides an AI-powered, cloud-based platform to create patient-specific surgical guides and implants from medical imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, 3D Printing, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CustoMED Comparables
Compare CustoMED with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enhatch | 81% | |
| Axial3D | 81% | |
| PeekMed | 80% |
For institutional investors. Book with your work email.
CustoMED Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CustoMED Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| Israel Innovation Authority | Seed |
| Varana Capital | Seed |
| Longevity Venture Partners | Seed |
| Flag Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Apr 19, 2026
Monthly visitors grew 155% MoM, reaching 3.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 20, 2026
Customed Ltd. and Myrava, Inc. plan to develop an automated, in-hospital 3D-printing system for custom orthopedic tools designed for use even in emergency surgeries.
- is_developingOct 20, 2026
Customed Ltd. plans to develop the system with Myrava for custom orthopedic tools designed for use even in emergency surgeries.
For institutional investors. Book with your work email.
CustoMED Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CustoMED's valuation, stock price, and market status.
Is CustoMED a public or private company?
CustoMED is a private company.
What is the current stock price of CustoMED?
CustoMED is a private company, so its shares have no public market price. Caplight tracks CustoMED's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CustoMED worth (valuation)?
Valuation information for CustoMED is not publicly available.
Can I buy CustoMED stock?
CustoMED shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CustoMED's last funding round?
CustoMED's most recent funding round was Seed on October 29, 2025.
Who are the main investors in CustoMED?
Key investors in CustoMED include Israel Innovation Authority, Israel Innovation Authority, Varana Capital, Longevity Venture Partners, Flag Capital.
Will CustoMED IPO soon?
No public IPO plans have been announced for CustoMED.
How can I track CustoMED secondary market activity?
Caplight tracks bids, offers, and trades in CustoMED's shares on secondary markets.